Comparison of 5-year outcomes of zotarolimus-eluting stents and everolimus-eluting stents / 中国介入心脏病学杂志
Chinese Journal of Interventional Cardiology
;
(4): 341-344, 2018.
Article
Dans Chinois
| WPRIM
| ID: wpr-702350
ABSTRACT
Objective To compare 5-year clinical outcomes of the safety and efficacy of zotarolimus-eluting stent(ZES)and everolimus-eluting stent(EES).Methods A total of 480 patients receiving either ZES(n=244)or EES(n=236)placement from January 2011 to December 2012 in Wuhan Asia Heart Hospital were included in this study.The primary end point of the study was 5-year all-cause mortality including acute myocardial infarction,and target vessel revascularization after the index EES/ZES placement.The secondary end points included subsequent in-stent restenosis and in-stent occlusion at 5 years.Results There were no significant differences in all-cause mortality and acute myocardial infarction outcomes between the ZES and the EES groups(P>0.05).Compared with patients receiving EES,patients receiving ZES had a significantly higher rate of 5-year target vessel revascularization(10.2%vs.5.1%,P=0.040),in-stent restenosis(11.5%vs.5.9%,P=0.036),and in-stent occlusion(6.1%vs.2.1%,P=0.038).Conclusions At 5 years,patients receiving EES generally had better or comparable long-term outcomes compared with patients receiving ZES.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Interventional Cardiology
Année:
2018
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS